Dr. Ray O’Connor examines recent clinical studies on allergic rhinitis and asthma. The International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis 2023 provides an update on the best evidence related to allergic rhinitis, covering various topics and recommendations. Another paper explores the use of biologics like Omalizumab and Dupilumab in treating allergic rhinitis, showing positive results. In terms of asthma, a Cochrane review found that increasing doses of inhaled corticosteroids during exacerbations did not reduce the need for intervention or unscheduled visits. Additionally, switching to a dry powder inhaler for asthma maintenance therapy significantly reduced greenhouse gas emissions without impacting asthma control.
Source link
You might be interested in…Allergic Rhinitis and Asthma
